STOCK TITAN

Vaxcyte, Inc. (PCVX) Net Income by Year

PCVX

Vaxcyte, Inc. reported a net loss of $767K in fiscal year 2025. This represents a decrease of 65.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Vaxcyte, Inc. has filed alongside them.

FY2025 annual
Net Income -$767K
YoY -65.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PCVX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY22DEF 14AFY21DEF 14AFY2010-KFY1910-KFY1810-K
Net Income-$767K-65.2%-$464K-15.3%-$402K-80.0%-$223K-123.3%-$100K+99.9%-$89.2M-77.5%-$50.3M-70.5%-$29.5M

PCVX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$284.3M-70.7%-$320.6M-127.8%N/A-$212.8M-106.4%-$166.6M-29.4%-$140.7M-48.1%N/A-$103.1M-11.3%-$128.7M-88.3%-$95.0M-57.2%N/A-$92.7M-60.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Vaxcyte, Inc. financials

Frequently Asked Questions

What was Vaxcyte, Inc.'s net income in fiscal year 2025?

Vaxcyte, Inc. reported a net loss of $767K in fiscal year 2025.

How fast is Vaxcyte, Inc.'s net income growing?

Vaxcyte, Inc. (PCVX) net income fell by 65.2% year over year, from -$464K to -$767K in fiscal year 2025.

How has Vaxcyte, Inc.'s net income changed over the years?

Across the 8 fiscal years this page covers, Vaxcyte, Inc. (PCVX) net income went from -$29.5M in fiscal year 2018 to -$767K in fiscal year 2025.

Vaxcyte, Inc. (PCVX) reported -$284.3M in net income in Q2 2026. This represents a decrease of 70.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Vaxcyte, Inc. (PCVX) reported on that line in every period on record.